Akt activation is required for TGF-β1-induced Osteoblast differentiation of MC3T3-E1 Pre-osteoblasts

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Suzuki, Eiichi ^a   Ochiai Shino, Hiromi ^a   Aoki, Hideto ^a   Onodera, Shoko ^a   Saito, Akiko ^a   Saito, Atsushi ^a   Azuma, Toshifumi ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; MESSENGER RNA; OSTEOCALCIN; PROTEIN KINASE B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; AKT1 PROTEIN, MOUSE; ATRNL1 PROTEIN, MOUSE; GENETIC MARKER; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; MC3T3 E1 CELL; MINERALIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ANIMAL; BONE DEVELOPMENT; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC MARKER; METABOLISM; MOUSE; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; GENETIC MARKERS; MEMBRANE PROTEINS; MICE; OSTEOBLASTS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84916204802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112566     Document Type: Article

References (45)

1. Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal diseases. Lancet 366: 1809-1820.
2. Susin C, Wikesjö UME (2013) Regenerative periodontal therapy: 30 years of lessons learned and unlearned. Periodontol 2000 62: 232-242.
3. Stavropoulos A, Wikesjö UME (2012) Growth and differentiation factors for periodontal regeneration: a review on factors with clinical testing. J Periodontal Res 47: 545-553.
4. Rios HF, Lin Z, Oh B, Park CH, Giannobile WV (2011) Cell-and gene-based therapeutic strategies for periodontal regenerative medicine. J Periodontol 82: 1223-1237.
5. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA (2009) Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9: 447-453.
6. Ota K, Quint P, Ruan M, Pederson L, Westendorf JJ, et al. (2013) TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts. Endocrinology 154: 3745-3752.
7. Janssens K, ten Dijke P, Janssens S, Van Hul W (2005) Transforming growth factor-beta1 to the bone. Endocr Rev 26: 743-774.
8. Centrella M, McCarthy TL, Canalis E (1987) Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262: 2869-2874.
9. Centrella M, Horowitz MC,Wozney JM, McCarthy TL (1994) Transforming growth factor-beta gene family members and bone. Endocr Rev 15: 27-39.
10. Centrella M, Casinghino S, Kim J, Pham T, Rosen V, et al. (1995) Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol Cell Biol 15: 3273-3281.
11. Zhao L, Jiang S, Hantash BM (2010) Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells. Tissue Eng Part A 16: 725-733.
12. Lee K-S, Hong S-H, Bae S-C (2002) Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21: 7156-7163.
13. Zhang H, Ahmad M, Gronowicz G (2003) Effects of transforming growth factor-beta 1 (TGF-beta1) on in vitro mineralization of human osteoblasts on implant materials. Biomaterials 24: 2013-2020.
14. Lee J-Y, Kim K-H, Shin S-Y, Rhyu I-C, Lee Y-M, et al. (2006) Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules. J Biomed Mater Res A 76: 530-539.
15. Ripamonti U, Ferretti C, Teare J, Blann L (2009) Transforming growth factor-beta isoforms and the induction of bone formation: implications for reconstructive craniofacial surgery. J Craniofac Surg 20: 1544-1555.
16. Noda M (1989) Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells. Endocrinology 124: 612-617.
17. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R (2001) TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20: 2254-2272.
18. Kaji H, Naito J, Sowa H, Sugimoto T, Chihara K (2006) Smad3 differently affects osteoblast differentiation depending upon its differentiation stage. Horm Metab Res 38: 740-745.
19. Cantrell DA (2001) Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114: 1439-1445.
20. Mukherjee A, Rotwein P (2009) Akt promotes BMP2-mediated osteoblast differentiation and bone development. J Cell Sci 122: 716-726.
21. Guntur AR, Rosen CJ (2011) The skeleton: a multi-functional complex organ: new insights into osteoblasts and their role in bone formation: the central role of PI3Kinase. J Endocrinol 211: 123-130.
22. Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 Pt 3: 561-576.
23. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
24. Chen G, Deng C, Li Y (2012) TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8: 272-288.
25. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, et al. (2002) Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277: 33361-33368.
26. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, et al. (2004) Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166: 85-95.
27. Osyczka AM, Leboy PS (2005) Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146: 3428-3437.
28. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, et al. (2007) Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad Sci U S A 104: 2259-2264.
29. Guntur AR, Rosen CJ (2011) The skeleton: a multi-functional complex organ: new insights into osteoblasts and their role in bone formation: the central role of PI3Kinase. J Endocrinol 211: 123-130.
30. Ochiai H, Okada S, Saito A, Hoshi K, Yamashita H, et al. (2012) Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiation. J Biol Chem 287: 22654-22661.
31. Kadowaki T, Tobe K, Honda-Yamamoto R, Tamemoto H, Kaburagi Y, et al. (1996) Signal transduction mechanism of insulin and insulin-like growth factor-1. Endocr J 43 Suppl: S33-41.
32. Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, et al. (2000) Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105: 935-943.
33. Kanaan RA, Kanaan LA (2006) Transforming growth factor beta1, bone connection. Med Sci Monit 12: RA164-9.
34. Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K (2002) Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J Biol Chem 277: 36024-36031.
35. Ramirez-Yañez GO, Hamlet S, Jonarta A, Seymour GJ, Symons AL (2006) Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study. Prostaglandins Leukot Essent Fatty Acids 74: 183-192.
36. Matsunobu T, Torigoe K, Ishikawa M, de Vega S, Kulkarni AB, et al. (2009) Critical roles of the TGFbeta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev Biol 332: 325-338.
37. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, et al. (2001) Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29: 323-330.
38. Chen L-L, Huang M, Tan J-Y, Chen X-T, Lei L-H, et al. (2013) PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells. Tissue Eng Part A 19: 2226-2232.
39. Choi JY, Lee BH, Song KB, Park RW, Kim IS, et al. (1996) Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells. J Cell Biochem 61: 609-618.
40. Peng X, Xu P, Chen M-L, Hahn-Windgassen A, Skeen J, et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365.
41. Ulici V, Hoenselaar KD, Agoston H, McErlain DD, Umoh J, et al. (2009) The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone 45: 1133-1145.
42. Lian N, Lin T, Liu W, Wang W, Li L, et al. (2012) Transforming growth factor b suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis. J Biol Chem 287: 35975-35984.
43. Yokota J, Chosa N, Sawada S, Okubo N, Takahashi N, et al. (2014) PDGF-induced PI3K-mediated signaling enhances the TGF-β-induced osteogenic differentiation of human mesenchymal stem cells in a TGF-β-activated MEK-dependent manner. Int J Mol Med 33: 534-542.
44. Remy I, Montmarquette A, Michnick SW (2004) PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 6: 358-365.
45. Matarese G, Isola G, Anastasi GP, Favaloro A, Milardi D, et al. (2012) Immunohistochemical analysis of TGF-β1 and VEGF in gingival and periodontal tissues: a role of these biomarkers in the pathogenesis of scleroderma and periodontal disease. Int J Mol Med 30: 502-508.